Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 1230338)

Published in CMAJ on May 04, 1999

Authors

E Burgess1, R Lewanczuk, P Bolli, A Chockalingam, H Cutler, G Taylor, P Hamet

Author Affiliations

1: Division of Nephrology, Faculty of Medicine, University of Calgary, Alta.

Articles cited by this

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93

Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ (1993) 6.20

Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am J Epidemiol (1995) 4.62

A prospective study of nutritional factors and hypertension among US men. Circulation (1992) 3.51

Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27

Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med (1996) 2.62

Blood pressure and nutrient intake in the United States. Science (1984) 2.33

Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA (1996) 2.08

Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med (1987) 1.95

Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension (1980) 1.86

Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ (1994) 1.83

Moderate potassium supplementation in essential hypertension. Lancet (1982) 1.83

The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med (1990) 1.54

Effect of magnesium on blood pressure. Br Med J (Clin Res Ed) (1983) 1.54

Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet (1984) 1.48

Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension (1996) 1.45

Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med (1985) 1.43

The association between blood pressure, age, and dietary sodium and potassium: a population study. Circulation (1988) 1.43

Effects of dietary calcium from dairy products on ambulatory blood pressure in hypertensive men. J Am Diet Assoc (1992) 1.41

Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens (1991) 1.39

Dietary calcium supplementation as a treatment for mild hypertension. J Am Board Fam Pract (1991) 1.39

The evaluation of the scientific evidence for a relationship between calcium and hypertension. J Nutr (1995) 1.39

Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis (1980) 1.38

Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr (1987) 1.30

Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ (1999) 1.26

Calcium intake and the relationship of dietary sodium and potassium to blood pressure. Am J Clin Nutr (1988) 1.24

Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study. BMJ (1990) 1.20

Alcohol, nutrient intake, and hypertension in US adults. JAMA (1985) 1.19

Sodium and potassium in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.18

Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action. Lancet (1981) 1.17

Risk factors for hypertension in a national cohort study. Hypertension (1991) 1.12

Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish heart health study. BMJ (1988) 1.11

Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr (1994) 1.09

Potassium supplementation reduces clinic and ambulatory blood pressure in elderly hypertensive patients. J Hypertens (1992) 1.09

A prospective study of nutritional factors and hypertension among US women. Circulation (1989) 1.08

Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial. Arch Intern Med (1996) 1.07

Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. J Am Soc Nephrol (1992) 1.06

Sodium restriction and potassium supplementation in young people with mildly elevated blood pressure. J Hypertens (1987) 1.06

Australian National Health and Medical Research Council dietary salt study in mild hypertension. J Hypertens Suppl (1986) 1.05

Randomised double-blind cross-over trial of potassium on blood-pressure in normal subjects. Lancet (1982) 1.02

Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Br Med J (Clin Res Ed) (1985) 1.01

Diet, alcohol, body mass, and social factors in relation to blood pressure: the Caerphilly Heart Study. J Epidemiol Community Health (1987) 1.01

The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens (1993) 0.99

Dietary calcium and blood pressure in National Health and Nutrition Examination Surveys I and II. Hypertension (1986) 0.98

Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) (1985) 0.98

Increasing the dietary potassium intake reduces the need for antihypertensive medication. Ann Intern Med (1991) 0.96

Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial. Ann Intern Med (1985) 0.95

Interrelationships between blood pressure, sodium, potassium, serum cholesterol, and protein intake in Japanese. Hypertension (1984) 0.95

Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. Hypertension (1991) 0.95

Blood pressure in blacks and whites and its relationship to dietary sodium and potassium intake. J Chronic Dis (1984) 0.94

Potassium supplementation in blacks with mild to moderate essential hypertension. J Hypertens (1986) 0.93

Effect of calcium supplementation on diastolic blood pressure in young people with mild hypertension. Lancet (1986) 0.93

Role of adequate dietary calcium intake in the prevention and management of salt-sensitive hypertension. Am J Clin Nutr (1997) 0.92

Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension. Hypertension (1987) 0.92

Diet, blood pressure, and multicollinearity. Hypertension (1985) 0.92

Blood pressure and hormonal changes following alteration in dietary sodium and potassium in young men with and without a familial predisposition to hypertension. Lancet (1981) 0.92

OBSERVATIONS ON THE MANAGEMENT OF HYPERTENSION. Can Med Assoc J (1931) 0.91

Relationship of dietary sodium, potassium, calcium, and magnesium with blood pressure. Belgian Interuniversity Research on Nutrition and Health. Hypertension (1988) 0.91

Controlled trial of long term oral potassium supplements in patients with mild hypertension. Br Med J (Clin Res Ed) (1987) 0.90

Low blood pressure in vegetarians: the possible role of potassium. Am J Clin Nutr (1983) 0.90

Effect of changes in dietary sodium and potassium on blood pressure and cellular electrolyte handling in young normotensive subjects. J Hypertens (1985) 0.89

Dietary potassium and blood pressure in a population. Am J Clin Nutr (1984) 0.89

Dietary alcohol, calcium, and potassium. Independent and combined effects on blood pressure. Circulation (1989) 0.87

Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Am J Hypertens (1991) 0.87

Effects of potassium on sodium balance, renin, noradrenaline and arterial pressure. J Hypertens (1985) 0.85

Does potassium lower blood pressure by increasing sodium excretion? A metabolic study in patients with mild to moderate essential hypertension. J Hypertens Suppl (1983) 0.85

Long-term magnesium supplementation in essential hypertension. Cardiology (1992) 0.85

The influence of oral potassium citrate/bicarbonate on blood pressure in essential hypertension during unrestricted salt intake. Klin Wochenschr (1991) 0.83

Effect of potassium supplementation combined with dietary sodium reduction on blood pressure in men taking antihypertensive medication. J Hypertens Suppl (1988) 0.83

Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives. J Hum Hypertens (1991) 0.83

Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long term diuretic treatment. Br Med J (Clin Res Ed) (1986) 0.82

Calcium-rich foods and blood pressure: findings from the Italian National Research Council Study (the Nine Communities Study). Am J Epidemiol (1988) 0.82

Blood pressure response to potassium supplementation in normotensive adults and children. Hypertension (1987) 0.81

Combinations of potassium, calcium, and magnesium supplements in hypertension. Hypertension (1995) 0.80

Controlled trial of long-term oral calcium supplementation in essential hypertension. Hypertension (1986) 0.80

Placebo-controlled trial of potassium supplements in black patients with mild essential hypertension. J Cardiovasc Pharmacol (1989) 0.80

Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. J Intern Med (1994) 0.79

Studies on the hypotensive effect of high potassium intake in patients with essential hypertension. Clin Sci (Lond) (1981) 0.79

Potassium supplementation does not lower blood pressure in normotensive women. J Hypertens (1986) 0.79

Controlled trial of low calcium versus high calcium intake in mild hypertension. J Hypertens (1988) 0.78

Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet. Clin Exp Pharmacol Physiol (1989) 0.78

Epidemiological evidence of an interaction between calcium and sodium intake impacting on blood pressure. A Montréal study. Am J Hypertens (1992) 0.78

Habitual dietary calcium intake and blood pressure change around the menopause: a longitudinal study. Int J Epidemiol (1992) 0.78

Does oral calcium supplementation lower high blood pressure? A double blind study. J Hypertens (1987) 0.77

The blood pressure effects of calcium supplementation in humans of known sodium responsiveness. Am J Hypertens (1993) 0.77

Effect of calcium supplementation in an older population with mildly increased blood pressure. Am J Hypertens (1992) 0.76

Effect of calcium carbonate on blood pressure in normotensive and hypertensive people. Hypertension (1989) 0.76

Gerard Piel: President-Elect of the AAAS. Science (1984) 0.76

Calcium intake and blood pressure in elderly women. Am J Epidemiol (1992) 0.76

Double-blind randomized, crossover trial of calcium supplementation in essential hypertension. J Hypertens (1988) 0.76

Electrolyte profiles in a hypertensive population: The Newfoundland Study. Clin Invest Med (1987) 0.76

The inconsistent effects of calcium supplements upon blood pressure in primary hypertension. Am J Med Sci (1987) 0.76

Blood pressure responses of white men with hypertension to two low-sodium metabolic diets with different levels of dietary calcium. J Am Diet Assoc (1995) 0.76

Arterial blood pressure and urinary electrolytes. J Chronic Dis (1984) 0.76

Potassium effects on blood pressure: is the conjugate anion important? J Hum Hypertens (1990) 0.76

Urinary electrolytes and blood pressure in three Yi farmer populations, China. Hypertension (1989) 0.76

Short-term augmented calcium intake has no effect on sodium homeostasis. Clin Pharmacol Ther (1986) 0.75

Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am J Clin Nutr (1990) 0.75

Articles by these authors

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21

Awareness, treatment, and control of hypertension in Canada. Am J Hypertens (1997) 4.76

Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol (2000) 4.10

Guideline for the management of breast lumps. Can J Surg (1998) 4.02

Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol (1994) 3.27

Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology (1984) 3.27

Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 2.98

Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens (2001) 2.96

1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension. CMAJ (1999) 2.61

A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med (2001) 2.50

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J Virol (1987) 2.41

Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest (1987) 2.40

Respiratory syncytial virus. Brief review. Arch Virol (1985) 2.31

Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res (1997) 2.30

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28

Respiratory syncytial virus infection in mice. Infect Immun (1984) 2.14

What more do we have to do? Br Dent J (1992) 2.04

The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med (1990) 2.03

Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology (1987) 2.02

Community care. Br Dent J (2001) 2.01

Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A (1992) 1.93

Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J Leukoc Biol (1999) 1.88

RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88

Changes in elastic fibres in the small airways and alveoli in COPD. Eur Respir J (2008) 1.87

Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes. CMAJ (1993) 1.86

A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther (1996) 1.80

Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76

Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br J Clin Pharmacol (1976) 1.75

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol (1992) 1.73

Carcinoembryonic antigen in faeces. Br Med J (1972) 1.71

Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice. Immunology (1976) 1.71

Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. J Rheumatol (2001) 1.71

Selected aspects of cardiac tumors in infancy and childhood. Pediatr Cardiol (2000) 1.69

Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J (1997) 1.69

The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll. Structure (1995) 1.65

Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest (1996) 1.65

Early experience with laparoscopic approach for adrenalectomy. Surgery (1993) 1.61

Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure (1994) 1.61

Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med (1986) 1.60

Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun (1984) 1.59

Changing fruit and vegetable consumption among children: the 5-a-Day Power Plus program in St. Paul, Minnesota. Am J Public Health (1998) 1.59

Cardioesophageal reflex: a mechanism for "linked angina" in patients with angiographically proven coronary artery disease. J Am Coll Cardiol (1996) 1.57

The Milton survey: Part 1, General methods, height, weight and 24-hour excretion of sodium, potassium, calcium, magnesium and creatinine. N Z Med J (1978) 1.55

Studies on the aetiology of byssinosis. Br J Ind Med (1971) 1.53

Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. J Gen Virol (1985) 1.52

X-ray analyses of aspartic proteinases. II. Three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 A resolution. J Mol Biol (1990) 1.52

Peak expiratory flow meters (PEFMs)--who uses them and how and does education affect the pattern of utilisation? Aust N Z J Med (1994) 1.51

Creating a Canadian stroke system. CMAJ (2001) 1.50

Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: an Italian multicenter study. J Psychosom Res (1996) 1.49

Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice. Infect Immun (1985) 1.49

Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin. Ann Pharmacother (1999) 1.47

The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol (1994) 1.46

The accreditation of vocational training programmes--results of a pilot survey. J R Coll Gen Pract (1974) 1.46

Screening for fragile X syndrome: information needs for health planners. J Med Screen (1997) 1.46

Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother (2012) 1.45

Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun (1995) 1.44

Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44

Fish consumption and cardiovascular mortality in Canada: an inter-regional comparison. Am J Prev Med (1988) 1.44

A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio. Arch Dis Child (2007) 1.42

Urban woodlands: their role in reducing the effects of particulate pollution. Environ Pollut (1998) 1.42

Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun (1993) 1.42

The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. Can J Cardiol (2001) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Clinical assessment of blood pressure. J Hum Hypertens (1990) 1.41

Arginine derivatives and uraemia. Lancet (1992) 1.40

Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide. Nephrol Dial Transplant (1989) 1.39

Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect (2007) 1.39

Validation study of a Doppler-tipped angiographic catheter for measurement of a coronary flow reserve. Am J Cardiol (1993) 1.38

Baseline fruit and vegetable intake among adults in seven 5 a day study centers located in diverse geographic areas. J Am Diet Assoc (1999) 1.38

The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase. FEBS Lett (1985) 1.36

Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol (1997) 1.36

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia (2010) 1.36

Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol (1996) 1.35

Modelling supply and demand of bioenergy from short rotation coppice and Miscanthus in the UK. Bioresour Technol (2010) 1.35

Influence of environmental temperature on the blood pressure of hypertensive patients in Montréal. Am J Hypertens (1991) 1.34

Changes in nasal airways resistance on antigenic challenge in allergic rhinitis. Clin Allergy (1971) 1.34

Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med (1984) 1.34

Assessment of the genetic causes of recessive childhood non-syndromic deafness in the UK - implications for genetic testing. Clin Genet (2005) 1.33

The role of cutaneous diphtheria in the acquisition of immunity. J Hyg (Lond) (1968) 1.33

British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Endemic goitre in the Gilgit Agency, West Pakistan with an appendix on dermatoglyphics and taste-testing. Philos Trans R Soc Lond B Biol Sci (1972) 1.32

The natural history of developmental dysplasia of the hip after early supervised treatment in the Pavlik harness. A prospective, longitudinal follow-up. J Bone Joint Surg Br (2002) 1.31

Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol (2000) 1.30

5-a-day Power Plus: process evaluation of a multicomponent elementary school program to increase fruit and vegetable consumption. Health Educ Behav (2000) 1.30

Surveillance for stroke in Canada. Health Rep (1994) 1.30

Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension (2001) 1.30

Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev (2001) 1.30

A comparison of three vaccines against respiratory syncytial virus in calves. J Hyg (Lond) (1984) 1.27

Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol (1985) (1992) 1.27

Experience with papillary and solid epithelial neoplasms of the pancreas in children. J Pediatr Surg (1998) 1.27

Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ (1999) 1.26

Effect of immunosuppression on arthritis in mice induced by Mycoplasma pulmonis. Ann Rheum Dis (1974) 1.26

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia (2009) 1.26

Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol (1997) 1.26

[Disturbance of intestinal absorption following metformin therapy (observations on the mode of action of biguanides]. Diabetologia (1969) 1.24